• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荜茇酰胺通过增强活性氧和DNA损伤诱导胰腺癌细胞死亡。

Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damage.

作者信息

Dhillon Harsharan, Chikara Shireen, Reindl Katie M

机构信息

Department of Biological Sciences, North Dakota State University, Fargo, ND 58105, USA.

出版信息

Toxicol Rep. 2014;1:309-318. doi: 10.1016/j.toxrep.2014.05.011.

DOI:10.1016/j.toxrep.2014.05.011
PMID:25530945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4268771/
Abstract

Pancreatic cancer is one of the most deadly cancers with a nearly 95% mortality rate. The poor response of pancreatic cancer to currently available therapies and the extremely low survival rate of pancreatic cancer patients point to a critical need for alternative therapeutic strategies. The use of reactive oxygen species (ROS)-inducing agents has emerged as an innovative and effective strategy to treat various cancers. In this study, we investigated the potential of a known ROS inducer, piperlongumine (PPLGM), a bioactive agent found in long peppers, to induce pancreatic cancer cell death in cell culture and animal models. We found that PPLGM inhibited the growth of pancreatic cancer cell cultures by elevating ROS levels and causing DNA damage. PPLGM-induced DNA damage and pancreatic cancer cell death was reversed by treating the cells with an exogenous antioxidant. Similar to the studies, PPLGM caused a reduction in tumor growth in a xenograft mouse model of human pancreatic cancer. Tumors from the PPLGM-treated animals showed decreased Ki-67 and increased 8-OHdG expression, suggesting PPLGM inhibited tumor cell proliferation and enhanced oxidative stress. Taken together, our results show that PPLGM is an effective inhibitor for and growth of pancreatic cancer cells, and that it works through a ROS-mediated DNA damage pathway. These findings suggest that PPLGM has the potential to be used for treatment of pancreatic cancer.

摘要

胰腺癌是最致命的癌症之一,死亡率近95%。胰腺癌对现有疗法反应不佳,患者生存率极低,这表明迫切需要替代治疗策略。使用活性氧(ROS)诱导剂已成为一种治疗各种癌症的创新有效策略。在本研究中,我们研究了一种已知的ROS诱导剂——荜茇酰胺(PPLGM)(一种在长胡椒中发现的生物活性剂)在细胞培养和动物模型中诱导胰腺癌细胞死亡的潜力。我们发现PPLGM通过提高ROS水平和导致DNA损伤来抑制胰腺癌细胞培养物的生长。用外源性抗氧化剂处理细胞可逆转PPLGM诱导的DNA损伤和胰腺癌细胞死亡。与这些研究类似,PPLGM在人胰腺癌异种移植小鼠模型中导致肿瘤生长减少。PPLGM处理动物的肿瘤显示Ki-67降低,8-OHdG表达增加,表明PPLGM抑制肿瘤细胞增殖并增强氧化应激。综上所述,我们的结果表明PPLGM是胰腺癌细胞生长的有效抑制剂,并且它通过ROS介导的DNA损伤途径起作用。这些发现表明PPLGM有潜力用于治疗胰腺癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc6/5598112/8d5082e964ef/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc6/5598112/4a7a50037b88/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc6/5598112/8fc779c1c25f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc6/5598112/b9d5385841a1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc6/5598112/07072ff6705f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc6/5598112/8d5082e964ef/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc6/5598112/4a7a50037b88/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc6/5598112/8fc779c1c25f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc6/5598112/b9d5385841a1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc6/5598112/07072ff6705f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc6/5598112/8d5082e964ef/gr5.jpg

相似文献

1
Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damage.荜茇酰胺通过增强活性氧和DNA损伤诱导胰腺癌细胞死亡。
Toxicol Rep. 2014;1:309-318. doi: 10.1016/j.toxrep.2014.05.011.
2
Activation of ERK signaling and induction of colon cancer cell death by piperlongumine.胡椒碱激活 ERK 信号通路诱导结肠癌细胞死亡。
Toxicol In Vitro. 2013 Sep;27(6):1626-33. doi: 10.1016/j.tiv.2013.04.006. Epub 2013 Apr 18.
3
Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells.培柏宁,一种生物碱,通过抑制 PI3K/Akt/mTOR 信号通路诱导人三阴性乳腺癌细胞发生 caspase 依赖性凋亡。
Apoptosis. 2014 Jul;19(7):1148-64. doi: 10.1007/s10495-014-0991-2.
4
JNK signaling pathway is involved in piperlongumine-mediated apoptosis in human colorectal cancer HCT116 cells.JNK信号通路参与了胡椒碱介导的人结肠直肠癌HCT116细胞凋亡。
Oncol Lett. 2015 Aug;10(2):709-715. doi: 10.3892/ol.2015.3371. Epub 2015 Jun 11.
5
Piperlongumine Induces Apoptosis in Colorectal Cancer HCT 116 Cells Independent of Bax, p21 and p53 Status.荜茇酰胺诱导结直肠癌HCT 116细胞凋亡,与Bax、p21和p53状态无关。
Anticancer Res. 2018 Nov;38(11):6231-6236. doi: 10.21873/anticanres.12978.
6
Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis.千里光碱通过诱导铁死亡迅速诱导人胰腺癌细胞死亡。
Int J Oncol. 2018 Mar;52(3):1011-1022. doi: 10.3892/ijo.2018.4259. Epub 2018 Jan 31.
7
Piperlongumine potentiates the effects of gemcitabine in and human pancreatic cancer models.胡椒碱增强吉西他滨在人胰腺癌模型中的作用。
Oncotarget. 2017 Dec 23;9(12):10457-10469. doi: 10.18632/oncotarget.23623. eCollection 2018 Feb 13.
8
Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.新型喹唑啉二酮类氧化还原调节剂作为胰腺癌治疗药物的设计与发现。
Biochim Biophys Acta. 2014 Jan;1840(1):332-43. doi: 10.1016/j.bbagen.2013.08.005. Epub 2013 Aug 15.
9
Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors.荜茇明碱通过活性氧(ROS)依赖性下调特异性蛋白转录因子。
Cancer Prev Res (Phila). 2017 Aug;10(8):467-477. doi: 10.1158/1940-6207.CAPR-17-0053. Epub 2017 Jul 3.
10
Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways.新型组蛋白去乙酰化酶抑制剂AR-42通过影响多种生化途径在胰腺癌细胞中展现出抗肿瘤活性。
PLoS One. 2017 Aug 22;12(8):e0183368. doi: 10.1371/journal.pone.0183368. eCollection 2017.

引用本文的文献

1
GSTP1 knockdown induces metabolic changes affecting energy production and lipid balance in pancreatic cancer cells.GSTP1基因敲低诱导代谢变化,影响胰腺癌细胞的能量产生和脂质平衡。
Mol Cell Oncol. 2025 Jun 14;12(1):2518773. doi: 10.1080/23723556.2025.2518773. eCollection 2025.
2
Unlocking the Potential of Bioactive Compounds in Pancreatic Cancer Therapy: A Promising Frontier.挖掘生物活性化合物在胰腺癌治疗中的潜力:一个充满希望的前沿领域。
Biomolecules. 2025 May 15;15(5):725. doi: 10.3390/biom15050725.
3
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity.

本文引用的文献

1
Activation of ERK signaling and induction of colon cancer cell death by piperlongumine.胡椒碱激活 ERK 信号通路诱导结肠癌细胞死亡。
Toxicol In Vitro. 2013 Sep;27(6):1626-33. doi: 10.1016/j.tiv.2013.04.006. Epub 2013 Apr 18.
2
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
3
Various modes of cell death induced by DNA damage.DNA 损伤诱导的各种细胞死亡方式。
通过对映体差异活性研究胰腺癌中的合成致死性和PARP抑制剂耐药性。
Cell Death Discov. 2025 Mar 16;11(1):106. doi: 10.1038/s41420-025-02382-3.
4
Piperlongumine induces apoptosis via the MAPK pathway and ERK‑mediated autophagy in human melanoma cells.千里光碱通过 MAPK 通路和 ERK 介导的自噬诱导人黑色素瘤细胞凋亡。
Int J Mol Med. 2023 Dec;52(6). doi: 10.3892/ijmm.2023.5318. Epub 2023 Oct 13.
5
Piperlongumine Induces Apoptosis and Cytoprotective Autophagy via the MAPK Signaling Pathway in Human Oral Cancer Cells.荜茇酰胺通过丝裂原活化蛋白激酶信号通路诱导人口腔癌细胞凋亡和细胞保护性自噬。
Biomedicines. 2023 Sep 1;11(9):2442. doi: 10.3390/biomedicines11092442.
6
Alkaloids as Natural NRF2 Inhibitors: Chemoprevention and Cytotoxic Action in Cancer.生物碱作为天然的NRF2抑制剂:癌症化学预防与细胞毒性作用
Pharmaceuticals (Basel). 2023 Jun 7;16(6):850. doi: 10.3390/ph16060850.
7
The promising potential of piperlongumine as an emerging therapeutics for cancer.荜茇明作为一种新兴的癌症治疗药物具有广阔的潜力。
Explor Target Antitumor Ther. 2021;2(4):323-354. doi: 10.37349/etat.2021.00049. Epub 2021 Aug 30.
8
Piperlongumine, a piper alkaloid, enhances the efficacy of doxorubicin in breast cancer: involvement of glucose import, ROS, NF-κB and lncRNAs.胡椒碱,一种胡椒生物碱,可增强阿霉素对乳腺癌的疗效:涉及葡萄糖转运、活性氧、核因子κB和长链非编码RNA。
Apoptosis. 2022 Apr;27(3-4):261-282. doi: 10.1007/s10495-022-01711-6. Epub 2022 Feb 4.
9
Piperlongumine Is an NLRP3 Inhibitor With Anti-inflammatory Activity.荜茇酰胺是一种具有抗炎活性的NLRP3抑制剂。
Front Pharmacol. 2022 Jan 12;12:818326. doi: 10.3389/fphar.2021.818326. eCollection 2021.
10
Role of Phytochemicals in Perturbation of Redox Homeostasis in Cancer.植物化学物质在癌症氧化还原稳态紊乱中的作用
Antioxidants (Basel). 2021 Jan 9;10(1):83. doi: 10.3390/antiox10010083.
Oncogene. 2013 Aug 15;32(33):3789-97. doi: 10.1038/onc.2012.556. Epub 2012 Dec 3.
4
Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy.KRAS 突变对接受一线吉西他滨为基础化疗的胰腺癌患者临床结局的影响。
Mol Cancer Ther. 2011 Oct;10(10):1993-9. doi: 10.1158/1535-7163.MCT-11-0269. Epub 2011 Aug 23.
5
Chemistry and biology of reactive oxygen species in signaling or stress responses.活性氧在信号转导或应激反应中的化学和生物学。
Nat Chem Biol. 2011 Jul 18;7(8):504-11. doi: 10.1038/nchembio.607.
6
Selective killing of cancer cells by a small molecule targeting the stress response to ROS.小分子通过靶向 ROS 应激反应选择性杀死癌细胞。
Nature. 2011 Jul 13;475(7355):231-4. doi: 10.1038/nature10167.
7
Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy.调控内源性 NQO1 水平鉴定了 lapachone 用于胰腺癌治疗的关键作用调节机制。
Clin Cancer Res. 2011 Jan 15;17(2):275-85. doi: 10.1158/1078-0432.CCR-10-1983. Epub 2011 Jan 11.
8
Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.姜黄素通过抑制 NFkappaB 和胰腺癌细胞及肿瘤生长取决于特异性蛋白下调。
J Biol Chem. 2010 Aug 13;285(33):25332-44. doi: 10.1074/jbc.M109.095240. Epub 2010 Jun 9.
9
Advanced pancreatic carcinoma: current treatment and future challenges.晚期胰腺癌:当前的治疗方法和未来的挑战。
Nat Rev Clin Oncol. 2010 Mar;7(3):163-72. doi: 10.1038/nrclinonc.2009.236. Epub 2010 Jan 26.
10
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.一项关于 imexon 联合吉西他滨作为晚期胰腺癌一线治疗的 I 期研究。
Cancer Chemother Pharmacol. 2010 Jul;66(2):287-94. doi: 10.1007/s00280-009-1162-y. Epub 2009 Oct 24.